Anitrazafen
From Wikipedia, the free encyclopedia
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
KEGG |
|
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C18H17N3O2 |
Molar mass | 307.353 g·mol−1 |
3D model (JSmol) | |
| |
InChI
| |
Anitrazifen is a drug displaying COX-2 inhibitor activity.
Non-steroidal anti-inflammatory drugs (NSAIDs) (primarily M01A and M02A, also N02BA) | |
---|---|
pyrazolones / pyrazolidines |
|
salicylates |
|
acetic acid derivatives and related substances |
|
oxicams |
|
propionic acid derivatives (profens) |
|
n-arylanthranilic acids (fenamates) |
|
COX-2 inhibitors (coxibs) |
|
other |
|
NSAID combinations | |
Key: underline indicates initially developed first-in-class compound of specific group; #WHO-Essential Medicines; †withdrawn drugs; ‡veterinary use. | |
|
Analgesics (N02A, N02B) | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Opioids |
| ||||||||||||||||
Paracetamol-type |
| ||||||||||||||||
NSAIDs |
| ||||||||||||||||
Cannabinoids |
| ||||||||||||||||
Ion channel modulators |
| ||||||||||||||||
Myorelaxants |
| ||||||||||||||||
Others |
| ||||||||||||||||
|
| |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Receptor (ligands) |
| ||||||||||||||||||||||||||
Enzyme (inhibitors) | |||||||||||||||||||||||||||
Others |
| ||||||||||||||||||||||||||
|
This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by . |
- v
- t
Retrieved from ""
Categories:
- Drugs not assigned an ATC code
- Nonsteroidal anti-inflammatory drugs
- COX-2 inhibitors
- Triazines
- Phenol ethers
- Musculoskeletal system drug stubs
Hidden categories:
- Chemical pages without DrugBank identifier
- Drugs with no legal status
- All stub articles